08 December 2000
Molecular and Cellular Events Associated with Ischemia/Reperfusion Injury
J Pratschke, M J WilhelmAnn Transplant 2000; 5(4): 29-35 :: ID: 497550
Abstract
Despite progressive improvement in the early outcome of solid organ transplants, their long-term rate of success remains limited, primarily by chronic rejection and patient death. Although the pathogenesis of chronic rejection is not completely understood, two major types of risk factors have been identified. The most important are immunological, related to genetic differences between donor and recipient and orchestrating a cascade of interrelated events which include the interaction between the major histocompatibility complex (MHC) antigens and T lymphocytes, the influence of co-stimulatory molecules, the activation of different leukocyte populations and the differential regulatory roles of cellassociated chemokines and other inflammatory molecules.
Keywords: adhesion molecules, oxygen-free radicals, polymorphonuclear luekocytes, Organ Transplantation
In Press
Original article
Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...Ann Transplant In Press; DOI: 10.12659/AOT.953761
Clinical Research
Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cel...Ann Transplant In Press; DOI: 10.12659/AOT.954230
Clinical Research
Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response ...Ann Transplant In Press; DOI: 10.12659/AOT.954574
Most Viewed Current Articles
24 Aug 2021 : Review article 21,978
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 18,247
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,856
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,762
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






